Biogen Inc.

BIIB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $1.57B $2.33B $1.31B $1.20B $602.6M $570.7M $514.5M $759.6M
Accounts Receivable $1.79B $1.44B $1.23B $1.29B $824.4M $686.8M $584.6M $605.3M
Inventory $902.7M $1.00B $893.4M $804.0M $659.0M $447.4M $326.8M $289.1M
Total Current Assets $7.87B $8.73B $6.70B $4.54B $3.18B $3.24B $2.98B $2.54B
Property, Plant & Equipment $3.18B $2.50B $2.19B $1.77B $1.75B $1.74B $1.57B $1.64B
Goodwill $4.63B $3.67B $2.66B $1.76B $1.23B $1.20B $1.15B $1.15B
Intangible Assets (Excl. Goodwill) $3.88B $3.81B $4.09B $4.03B $4.47B $1.63B $1.61B $1.77B
Total Assets $23.65B $22.88B $19.50B $14.31B $11.86B $10.13B $9.05B $8.09B
Liabilities
Accounts Payable $395.5M $279.8M $267.4M $229.2M $219.9M $204.0M $186.4M $162.5M
Total Current Liabilities $3.37B $3.42B $2.58B $2.22B $1.76B $1.66B $912.9M $1.05B
Long-Term Debt $5.94B $6.51B $6.52B $580.3M $592.4M $687.4M $1.02B $1.04B
Total Liabilities $11.05B $10.75B $10.13B $3.50B $3.24B $3.17B $2.62B $2.64B
Stockholders' Equity
Retained Earnings $15.81B $15.07B $12.21B $9.28B $6.35B $4.49B $3.11B $1.87B
Total Stockholders' Equity $12.61B $12.14B $9.37B $10.81B $8.62B $6.96B $6.43B $5.40B
← Newer Page 2 of 3 Older →